BSX vs COYA · P/E 20, rev $10.65B vs rev $7.9M
Boston Scientific Corp (BSX) versus Coya Therapeutics, Inc. Common Stock (COYA) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. COYA currently screens at market cap $118.0M.
Not investment advice. Open the BSX and COYA stock pages for the full models.
Not investment advice.